Over the last year, a good number of insiders have significantly increased their holdings in Recce Pharmaceuticals Ltd (ASX:RCE). This is encouraging because it indicates that insiders are more ...
Memorandum of Understanding (MoU) with leading Indonesian biomedical company PT Etana Biotechnologies MoU aims to facilitate late-stage clinical trials in Indonesia, supporting the Indonesian ...
RECCE ® 327 and RECCE ® 529 demonstrated dose-dependent activity in-vivo against SARS-CoV-2 virus in Syrian golden hamsters, a well-accepted model of infection Intranasal administration of both ...
Phase 1/2 trial of RECCE ® 327 (R327) is approved to start at the South West Sydney Limb Preservation and Wound Research Unit, located at the Ingham Institute of Medical Research Study will assess the ...
Hosted on MSN
Recce’s anti-infective topical gel fights hard against tough antibiotic-resistant burn wounds
Recce’s R327G highly effective against methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa infected wounds (in-vivo) R327G efficacy outcomes statistically significant and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results